Psychedelic Research

Picture1.png

Psychedelics and other psychoactive substances have the potential to catalyze profound psychological and spiritual growth. People from around the globe have spoken about the positive impact the psychedelic substances have had on their lives. And, today, a growing segment of the scientific community is exploring psychedelics using rigorous scientific methods within a safe and supportive clinical setting.

My research, direct experience on clinical trials, consultation with psychedelic pharmaceutical companies, and leadership at Fluence has made a significant impact in the world of psychedelic medicine.

Recent Publications and Presentations

  • Beachy, J., Hall, W., Thomas, C., Gorman, I., & C. O’Donnell, K. (2025). Relationality and Ethics in MDMA-Assisted Therapy. The American Journal of Bioethics, 25(1), 67–71. https://doi.org/10.1080/15265161.2024.2433445

  • Mitchell, J. M., Bogenschutz, M., Lilienstein, A., Harrison, C., Kleiman, S., Parker-Guilbert, K., ... & Doblin, R. (2021). MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine, 27(6), 1025-1033.

  • Gorman, I., Belser, A. B., Jerome, L., Hennigan, C., Shechet, B., Hamilton, S., ... & Feduccia, A. A. (2020). Posttraumatic Growth After MDMA‐Assisted Psychotherapy for Posttraumatic Stress Disorder. Journal of traumatic stress, 33(2), 161-170.